Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Atkinson, C. V
Right arrow Articles by Kirkham, S. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atkinson, C. V
Right arrow Articles by Kirkham, S. R
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Unlicensed uses for medication in a palliative care unit

Clea V Atkinson

Stephen R Kirkham

The aim of this study was to review the extent of drug use for unlicensed purposes in a palliative care unit. We carried out a prospective study of all patients with advanced malignancy admitted to a 10-bed specialist palliative care unit over a 4-month period. Prescriptions were assessed and compared with licensed prescribing indications. Seventy-six patients were included in the study; 689 prescriptions were made using 84 drugs to treat 34 different symptoms. Fifteen per cent of prescribing events were for unlicensed indications. We conclude that drugs are frequently used in the palliative care setting for purposes unsupported by product licences, although usually backed by literature. These drugs are often prescribed for symptoms which are difficult to control.

Key Words: drug utilization • neoplasms • palliative care • prescriptions • drugs

Palliative Medicine, Vol. 13, No. 2, 145-152 (1999)
DOI: 10.1191/026921699676057177
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Palliat MedHome page
C. Fonzo-Christe, C. Vukasovic, A.-F. Wasilewski-Rasca, and P. Bonnabry
Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review
Palliative Medicine, April 1, 2005; 19(3): 208 - 219.
[Abstract] [PDF]

Home page
 Palliat MedHome page
M. Bennett and K. Simpson
The use of drugs beyond licence in palliative care and pain management
Palliative Medicine, July 1, 2002; 16(5): 367 - 368.
[PDF]

Home page
 BMJHome page
H. Pavis and A. Wilcock
Prescribing of drugs for use outside their licence in palliative care: survey of specialists in the United Kingdom
BMJ, September 1, 2001; 323(7311): 484 - 485.
[Full Text] [PDF]

Home page
 Palliat MedHome page
I. Back
Syringe driver drug compatibility database and patient information leaflets on the Internet
Palliative Medicine, January 1, 2001; 15(1): 77 - 77.
[PDF]

Home page
 Palliat MedHome page
J. Todd and A. Davies
Use of unlicensed medication in palliative medicine
Palliative Medicine, July 1, 1999; 13(5): 446 - 446.
[PDF]

Home page
 Palliat MedHome page
C. V Atkinson and S. R Kirkham
Unlicensed uses for medication in a palliative care unit - correction
Palliative Medicine, June 1, 1999; 13(4): 354 - 354.
[PDF]